
Adjuvant activity can be greatly improved by appropriate formulation of cytosine-phosphorothioate-guanine oligodeoxynucleotides (CpG ODNs).
Theodore G. Clark is the director of Grad Studies in the Field of Immunology Department of Microbiology & Immunology, Cornell University, Ithaca, NY.
Adjuvant activity can be greatly improved by appropriate formulation of cytosine-phosphorothioate-guanine oligodeoxynucleotides (CpG ODNs).
Published: October 2nd 2010 | Updated: